Ambroxol
Spezifikationen
1217679-83-8CAS-Nummer
4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-olIUPAC-Name
C13H18Br2N2OChemische Formel
378.1 g/molMolekulargewicht
ambroxol; 18683-91-5; 107814-37-9; rac-cis-Ambroxol; Ambroxol EP Impurity D; 36557-04-7; 4-((2-amino-3,5-dibromobenzyl)amino)cyclohexan-1-ol; rac-cis-Ambroxol-d5; cis-4-((2-Amino-3,5-dibromobenzyl)amino)cyclohexanol; 4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol; Bisolvon metabolite VIII; Bromhexine-metabolite VIII; NA-872; trans-4-((2-Amino-3,5-dibromobenzyl)amino)cyclohexanol; C13H18Br2N2O; Tabcin; 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol; Ambroxol, cis-; Ambroxol [INN]; Cyclohexanol, 4-[[(2-amino-3,5-dibromophenyl)methyl]amino]-, trans-; 1217679-83-8; MFCD00242702; trans-4-((2-Amino-3,5-dibromobencil)amino)ciclohexanol; trans-4-((2-Amino-3,5-dibromobenzyl)amine)cyclohexanol; QH6ZT6J071; Cyclohexanol, 4-((2-amino-3,5-dibromobenzyl)amino)- (E)-; 4-{[(2-amino-3,5-dibromophenyl)methyl]amino}cyclohexan-1-ol; N-(2-Amino-3,4-dibromocyclohexyl)-trans-4-aminocyclohexanol; 4-Hydroxydemethylbromhexine, cis-; N-(trans-4-Hydroxycyclohexyl)-(2-amino-3,5-dibromobenzyl)-amine; N-(trans-p-Hydroxycyclohexyl)-(2-amino-3,5-dibromobenzyl)amine; Ambroxol (INN); MFCD28143339; 200168S0CL; trans-4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol; 4-[(2-amino-3,5-dibromo-phenyl)methylamino]cyclohexanol; N-(2-Amino-3,4-dibromociclohexil)-trans-4-aminociclohexanol; (1r,4r)-4-((2-amino-3,5-dibromobenzyl)amino)cyclohexan-1-ol; N-(trans-4-Hidroxiciclohexil)-(2-amino-3,5-dibromobencil)amina; N-(trans-4-Hydroxycyclohexyl)-2-amino-3,5-dibromobenzylamine; Ambroxol Base; rel-(1r,4r)-4-((2-Amino-3,5-dibromobenzyl)amino)cyclohexan-1-ol; (1r,4r)-4-{[(2-Amino-3,5-dibromophenyl)methyl]amino}cyclohexan-1-ol; Cyclohexanol, 4-(((2-amino-3,5-dibromophenyl)methyl)amino)-, trans-; Ambroxolum; Ambroxol [INN:BAN]; cis-4-(((2-Amino-3,5-dibromophenyl)methyl)amino)cyclohexanol; cis-4-[[(2-Amino-3,5-dibromophenyl)methyl]amino]cyclohexanol; Ambroxolum [INN-Latin]; Ambroxol EP Impurity D (cis-Ambroxol HCl/ Acebrophylline Impurity D); Cyclohexanol, 4-(((2-amino-3,5-dibromophenyl)methyl)amino)-, cis-; Ambroxol Hydrochloride Impurity D; NCGC00016781-04; EINECS 242-500-3; CAS-23828-92-4; Bromhexine Metabolite VIII; Amboxol; cis-Ambroxol; SR-05000001463; UNII-200168S0CL; Cyclohexanol, 4-[[(2-amino-3,5-dibromophenyl)methyl]amino]-, cis-; cis-4-[[(2-Amino-3,5-dibromophenyl)methyl]amino]cyclohexanol; cis-Ambroxol; cis-4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol; Ambroxol impurity D; Ambroxol (Standard); Tabcin (TN); Spectrum_001346; AMBROXOL [MI]; Prestwick0_000366; Prestwick1_000366; Prestwick2_000366; Prestwick3_000366; Spectrum2_001518; Spectrum3_000955; Spectrum4_001068; Spectrum5_001021; trans-4-((2-Amino-3,5-dibromobencil)amino)ciclohexanol [Spanish]; N-(2-Amino-3,4-dibromociclohexil)-trans-4-aminociclohexanol [Spanish]; AMBROXOL [WHO-DD]; EC 242-500-3; N-(trans-4-Hidroxiciclohexil)-(2-amino-3,5-dibromobencil)amina [Spanish]; UNII-QH6ZT6J071; Oprea1_766685; SCHEMBL18702; BSPBio_000491; KBioGR_001396; KBioSS_001826; MLS001306470; DivK1c_000027; SCHEMBL423712; SPBio_001595; SPBio_002412; BPBio1_000541; CHEMBL153479; orb1310168; SCHEMBL7855003; CHEMBL1477775; DTXSID8022583; SCHEMBL28472066; SCHEMBL29380194; BCBcMAP01_000092; CHEBI:92994; GTPL10692; HY-B1039R; KBio1_000027; KBio2_001826; KBio2_004394; KBio2_006962; KBio3_002050; DTXSID60860228; CHEBI:135590; NINDS_000027; Cyclohexanol, 4-[[(2-amino-3,5-dibromophenyl)methyl]amino]-; GLXC-08164; HMS2089D06; HMS2231B19; HMS3373J22; HMS3886M18; HMS5085K15; ALBB-022461; HY-B1039; MSK10228; SYB67983; BBL009896; BDBM50395322; EBC-26855; MFCD02093079; s5710; STK711075; AKOS005530704; AKOS015889660; AKOS027338704; Cyclohexanol, 4-(((2-amino-3,5-dibromophenyl)methyl)amino)-, trans- (9CI); AC-8362; Ambroxol hydrochloride impurity D [EP]; CCG-207907; CS-4558; DB06742; IA63605; SB17463; SB82866; IDI1_000027; SMP1_000014; NCGC00016781-01; NCGC00016781-02; NCGC00016781-08; NCGC00159399-02; NCGC00371077-02; AS-56023; IA156916; SMR000718792; VS-02240; 4-HYDROXYDEMETHYLBROMHEXINE, TRANS-; SBI-0051766.P002; AB00514663; CS-0323348; NS00005443; NS00073281; ST51014904; D07442; H33594; AB00053639_13; AB01275465-01; EN300-18524079; Q221637; SR-05000001463-1; AMBROXOL HYDROCHLORIDE IMPURITY D [EP IMPURITY]; BRD-K11223672-003-03-7; BRD-K11223672-003-04-5; BRD-K11223672-003-05-2; BRD-K56558538-003-02-8; BRD-K56558538-003-11-9; BRD-K56558538-003-12-7; 4-[(2-amino-3,5-dibromophenyl)methylamino-]cyclohexanol; 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexanol; (1s,4s)-4-((2-amino-3,5-dibromobenzyl)amino)cyclohexanol; 4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol, trans-; (1s,4s)-4-((2-amino-3,5-dibromobenzyl)amino)cyclohexan-1-ol; 4-[(2-Amino-3,5-dibromobenZyl)amino]cyclohexanol hydrochloride; trans-4-{[(2-amino-3,5-dibromophenyl)methyl]amino}cyclohexanol; Cyclohexanol, 4-[[(2-amino-3,5-dibromo-phenyl)methyl]amino]-, trans; (1S,4S)-4-{[(2-AMINO-3,5-DIBROMOPHENYL)METHYL]AMINO}CYCLOHEXAN-1-OLSynonyme
